TeraWulf Inc Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment PRFX Q2 2024 Earnings EPS Misses Estimates as Company Continues Development Stage Ball Corporation Q1 2026 Earnings EPS Beats Estimates by 885 on Strong Operational Performance Day One Biopharmaceuticals DAWN Q4 2025 Earnings EPS Miss Reflects RD Spend Amid PreRevenue Status CYD Q3 2020 Earnings Near InLine EPS as China Recovery Supports Demand